Driehaus Capital Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
Driehaus Capital Management's PRAX Position: Q3 2026 in Review
Driehaus Capital Management reduced its Praxis Precision Medicines (PRAX) stake by 12% in Q3 2026, selling an estimated $37.5M and leaving 845,773 shares worth $246M. The position accounts for 1.71% of the portfolio, ranked #4.
Driehaus Capital Management first reported a position in PRAX in Q1 2024 and has held it in 11 quarters since. The position peaked at $321M in Q2 2026. 281 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Driehaus Capital Management held 845,773 shares of Praxis Precision Medicines worth $246M as of Q3 2026.
- Driehaus Capital Management sold 113,275 Praxis Precision Medicines shares in Q3 2026, an estimated $37.5M.
- Praxis Precision Medicines made up 1.71% of Driehaus Capital Management's portfolio in Q3 2026, its #4 holding.
- Driehaus Capital Management first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 11 quarters since.
- Driehaus Capital Management's Praxis Precision Medicines position peaked at $321M in Q2 2026.
- 281 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Driehaus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.